Article Details
Retrieved on: 2024-06-26 22:16:54
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The collaboration with OpenAI is part of Lilly's strategy to combat drug-resistant pathogens through its Social Impact Venture Capital Portfolio.
Article found on: www.pharmexec.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here